Patents by Inventor Livia Del Carmen Escobar Orellana

Livia Del Carmen Escobar Orellana has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8129186
    Abstract: The present invention is directed to the use of choroid plexus cells and/or choroid plexus conditioned media for enhancing the growth, survival and/or maintenance of function of non-choroid plexus cells grown in long term or short term culture.
    Type: Grant
    Filed: April 18, 2006
    Date of Patent: March 6, 2012
    Assignee: Neurotrophincell Pty, Limited
    Inventors: Robert Bartlett Elliott, Stephen John Martin Skinner, Livia Del Carmen Escobar Orellana, Christopher Thanos
  • Publication number: 20090075375
    Abstract: The present invention is directed to the use of choroids plexus cells and/or choroids plexus conditioned media for enhancing the growth, survival and/or maintenance of function of non-choroid plexus cells grown in long term or short term culture.
    Type: Application
    Filed: September 15, 2008
    Publication date: March 19, 2009
    Applicant: Neurotrophincell Pty Limited
    Inventors: Robert Bartlett Elliott, Stephen John Martin Skinner, Livia Del Carmen Escobar Orellana, Christopher Thanos, Thorsten Gorba
  • Publication number: 20080286864
    Abstract: The present invention is directed to the use of choroid plexus cells and/or choroid plexus conditioned media for enhancing the growth, survival and/or maintenance of function of non-choroid plexus cells grown in long term or short term culture.
    Type: Application
    Filed: April 18, 2006
    Publication date: November 20, 2008
    Applicant: Neurotrophincell Pty Limited
    Inventors: Robert Bartlett Elliott, Stephen John Martin Skinner, Livia Del Carmen Escobar Orellana, Christopher Thanos
  • Publication number: 20080254090
    Abstract: Aggregates and their method of preparation suitable for implantation into a recipient in order to produce insulin in vivo. The methods involve culturing islet cells isolated from the pancreas of donor piglets with isolated Sertoli cells from the testes of donor piglets. A preferred period of culturing is 5 days and may be followed by a purification procedure.
    Type: Application
    Filed: June 24, 2004
    Publication date: October 16, 2008
    Applicant: DIABCELL PTY LIMITED
    Inventors: Stephen John Martin Skinner, Robert Bartlett Elliott, Livia Del Carmen Escobar Orellana